🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

850 results for “Elan” Clear

  1. SKY0402

    Pacira Ireland Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. SKY0402 300mg in healthy patients

    Pacira Ireland Limited

    Pain

    phase 1 small molecule completed

    1 trial

  3. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    HCV Infection

    phase 1 small molecule completed

    1 trial

  4. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Evaluation of Abuse Potential of Sativex

    phase 1 small molecule completed

    1 trial

  5. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Food Effect

    phase 1 small molecule completed

    1 trial

  6. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  7. Sativex and rifampicin

    Jazz Pharmaceuticals Ireland Limited

    Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4

    phase 1 small molecule completed

    1 trial

  8. Sativex® (Treatment A)

    Jazz Pharmaceuticals Ireland Limited

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  9. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Renal Insufficiency

    phase 1 small molecule completed

    1 trial

  10. Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

    Arrowhead Pharmaceuticals Ireland Limited

    spinocerebellar ataxia type 2

    phase 1 other active

    1 trial

  11. Study of safety and efficacy of DKY709 alone or in combination with PDR001 in patients with advanced solid tumors.

    Novartis Pharmaceuticals

    Nasopharyngeal Carcinoma, Triple Negative Breast Cancer, Microsatellite Stable Colorectal Cancer, Non-Small Cell Lung Cancer, Cutaneous Melanoma

    phase 1 other active

    1 trial

  12. Switch active lifestyles brought to you by MediaWise

    Lxo Ireland Designated Activity Company

    Overweight

    phase 1 other completed

    1 trial

  13. TAK-580

    Takeda

    Melanoma

    phase 1 small molecule terminated

    1 trial

  14. TD-0714

    Theravance Biopharma Ireland Umited

    Healthy Adults, Elderly Subjects

    phase 1 small molecule completed

    1 trial

  15. TD-0714

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  16. TD-1058

    Theravance Biopharma Ireland Umited

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 1 small molecule terminated

    1 trial

  17. TD-1211 Dose 1

    Theravance Biopharma Ireland Umited

    Constipation

    phase 1 small molecule completed

    1 trial

  18. TD-1439

    Theravance Biopharma Ireland Umited

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  19. TD-1439

    Theravance Biopharma Ireland Umited

    Healthy Adults, Elderly Subjects

    phase 1 small molecule completed

    1 trial

  20. TD-1473

    Theravance Biopharma Ireland Umited

    Ulcerative Colitis, Active Moderate

    phase 1 small molecule completed

    1 trial

  21. TD-1473

    Theravance Biopharma Ireland Umited

    Inflammatory Bowel Disease

    phase 1 small molecule completed

    1 trial

  22. TD-1473 - Dose A

    Theravance Biopharma Ireland Umited

    Inflammatory Bowel Diseases

    phase 1 small molecule completed

    1 trial

  23. TD-1473 [Tablet A]

    Theravance Biopharma Ireland Umited

    Intestinal Disorder

    phase 1 small molecule completed

    1 trial

  24. TD-1473 for SAD

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources